The S&P 500 is NARROW but 2 stocks are leading!

The S&P 500 is NARROW but 2 stocks are leading!

Index-level gains are increasingly driven by a very small group of AI infrastructure companies, but Micron and Broadcom look like beneficiaries to the trend. Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.

BUY ServiceNow and Salesforce stocks after the sell off?!

The AI trade has hit software names like ServiceNow and Salesforce, but only one of these companies offers a promising recovery prospect.  Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.

The case for China's stock market!

China's industrial boom hasn't led to index-level gains, but specific stocks in China are winning out. Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.

SpaceX IPO fuels Rocket Lab and AST SpaceMobile stocks!

The valuations of space-industry companies like Rocket Lab and AST SpaceMobile have boomed ahead of a projected SpaceX initial public offering in June 2026.  But should you buy them? Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.

2 biotech stocks that could BOOM with an acquisition!

Large pharmaceutical firms are currently seeking to acquire de-risked assets to compensate for significant revenue losses caused by expiring patents. The analysis highlights Crinetics Pharmaceuticals and Cytokinetics as the top candidates for acquisition. Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.